| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/10/2011 | US20110059552 Rubella e1 envelope protein variants and their use in detection of anti-rubella antibodies |
| 03/10/2011 | US20110059524 Human cdr-grafted antibody and antibody fragment thereof |
| 03/10/2011 | US20110059522 Nucleic acids encoding a house dust mite allergen, der p iii, and uses thereof |
| 03/10/2011 | US20110059507 Regulatable growth of filamentous fungi |
| 03/10/2011 | US20110059501 Protein Glycosylation |
| 03/10/2011 | US20110059486 Non-splicing variants of gp350/220 |
| 03/10/2011 | US20110059485 Plasmids from Thermophilic Organisms, Vectors Derived Therefrom, and Uses Thereof |
| 03/10/2011 | US20110059484 Process for producing polypeptides |
| 03/10/2011 | US20110059483 Molecular Probe for Imaging of Pancreatic Islets and Use of the Same |
| 03/10/2011 | US20110059471 Antibody having an immune-enhancement function |
| 03/10/2011 | US20110059461 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase |
| 03/10/2011 | US20110059443 Fluorescent gfp variant displaying highly increased fluorescence intensity without a spectral shift |
| 03/10/2011 | US20110059134 Prevention of recurrent viral disease |
| 03/10/2011 | US20110059131 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 03/10/2011 | US20110059129 Avian influenza virus vaccine and a method for preparing |
| 03/10/2011 | US20110059120 Glucan-based vaccines |
| 03/10/2011 | US20110059119 Immunogen against campylobacter infection |
| 03/10/2011 | US20110059110 Antibody (11c7) anti nogo-a and its pharmaceutical use |
| 03/10/2011 | US20110059091 Inhibitors of oncogenic isoforms and uses thereof |
| 03/10/2011 | US20110059086 Espfu nucleic acids and proteins and uses thereof |
| 03/10/2011 | US20110059076 Human serum albumin linkers and conjugates thereof |
| 03/10/2011 | US20110059064 Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) w/High Selectivity and Decrease the in vivo DTH-responses in Rats |
| 03/10/2011 | US20110059060 Thuricin cd, an antimicrobial for specifically targeting clostridium difficile |
| 03/10/2011 | US20110059057 Keratinocytes expressing exogenous angiogenic growth factors |
| 03/10/2011 | US20110059056 Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins |
| 03/10/2011 | US20110059042 Substituted il-15 |
| 03/10/2011 | US20110059041 Vaccine for treatment and prevention of herpes simplex virus infection |
| 03/10/2011 | US20110059021 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli |
| 03/10/2011 | US20110059015 Vaccine |
| 03/10/2011 | CA2780713A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 03/10/2011 | CA2773176A1 Treatment of diseases caused by bacterial exotoxins |
| 03/10/2011 | CA2773062A1 A bone regeneration agent comprising gelatin |
| 03/10/2011 | CA2772715A1 Mutant smoothened and methods of using the same |
| 03/10/2011 | CA2772695A1 Methods for improving malic acid production in filamentous fungi |
| 03/10/2011 | CA2772491A1 Multi-site modified sp1 polypeptides and uses thereof |
| 03/10/2011 | CA2771965A1 Treatment of vasculoproliferative conditions |
| 03/10/2011 | CA2771900A1 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 03/09/2011 | EP2293075A2 Method for diagnosing neuro-degenerative disease |
| 03/09/2011 | EP2293074A2 Method for diagnosing neuro-degenerative disease |
| 03/09/2011 | EP2293073A2 Method for diagnosing neuro-degenerative disease |
| 03/09/2011 | EP2293067A2 T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 03/09/2011 | EP2292802A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/09/2011 | EP2292780A2 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| 03/09/2011 | EP2292779A2 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| 03/09/2011 | EP2292778A1 Use of lentiviral triplex forming sequences for nuclear transfer of nucleotide sequences |
| 03/09/2011 | EP2292773A1 Genes and uses for plant improvement |
| 03/09/2011 | EP2292772A1 HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide |
| 03/09/2011 | EP2292770A2 Methods and means for producing proteins with predetermined post-translational modifications |
| 03/09/2011 | EP2292763A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 03/09/2011 | EP2292762A2 VMP-like sequences of pathogenic Borrelia species and strains |
| 03/09/2011 | EP2292761A1 Vascular adhesion molecules and modulation of their function |
| 03/09/2011 | EP2292760A2 Mammalian cytokines, receptors, related reagents and methods |
| 03/09/2011 | EP2292759A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 03/09/2011 | EP2292758A2 Uses of mammalian cytokine; related reagents |
| 03/09/2011 | EP2292662A2 Assay and reagents for quantifying hBNP |
| 03/09/2011 | EP2292658A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 03/09/2011 | EP2292657A1 Reduced side-effect hemoglobin compositions |
| 03/09/2011 | EP2292656A2 Method for preparing a Von Willebrand concentrate (FvW) by chromatographic means and FvW concentrate that can be thus obtained |
| 03/09/2011 | EP2292655A1 Peptides and related molecules that bind to tall-1 |
| 03/09/2011 | EP2292654A2 A lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
| 03/09/2011 | EP2292653A1 Novel insulin derivatives |
| 03/09/2011 | EP2292652A2 Interferons uses and compositions related thereto |
| 03/09/2011 | EP2292651A1 Methods and compositions for the prevention and treatment of anemia |
| 03/09/2011 | EP2292650A1 Methods and compositions for the prevention and treatment of anemia |
| 03/09/2011 | EP2292649A2 Therapeutic epitopes and uses thereof |
| 03/09/2011 | EP2292648A2 Small Streptococcus pyogenes antigens and their use |
| 03/09/2011 | EP2292647A2 Small Streptococcus pyogenes antigens and their use |
| 03/09/2011 | EP2292646A2 Small Streptococcus pyogenes antigens and their use |
| 03/09/2011 | EP2292645A2 Small Streptococcus pyogenes antigens and their use |
| 03/09/2011 | EP2292644A2 Small Streptococcus pyogenes antigens and their use |
| 03/09/2011 | EP2292643A1 Replikin peptides and uses thereof |
| 03/09/2011 | EP2292642A1 Immunomodulating compositions, uses therefor and processes for their production |
| 03/09/2011 | EP2292641A2 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 03/09/2011 | EP2292638A2 MAGE-C2 antigenic peptides and uses thereof |
| 03/09/2011 | EP2292637A2 Process for protein extraction |
| 03/09/2011 | EP2292634A2 Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292262A2 Use of modified novirhabdoviruses to obtain vaccines |
| 03/09/2011 | EP2292261A1 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| 03/09/2011 | EP2292259A2 Complement receptor 2 targeted complement modulators |
| 03/09/2011 | EP2292250A1 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline parvovirus and feline herpes virus |
| 03/09/2011 | EP2292249A1 Non-cytotoxic protein conjugates |
| 03/09/2011 | EP2292247A2 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 03/09/2011 | EP2292246A1 Recombinant Newcastle Disease Virus |
| 03/09/2011 | EP2292088A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 03/09/2011 | EP2291661A2 Identification of ligand recognition domains |
| 03/09/2011 | EP2291523A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 03/09/2011 | EP2291522A1 Herg mutants and uses thereof |
| 03/09/2011 | EP2291518A1 Mutations in the ns5b protein of the hcv |
| 03/09/2011 | EP2291400A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 03/09/2011 | EP2291399A2 Multivalent fibronectin based scaffold domain proteins |
| 03/09/2011 | EP2291397A1 Recombinant herpesvirus of turkeys encoding for interleukin-12 |
| 03/09/2011 | EP2291396A1 A modified galectin-2 and uses thereof |
| 03/09/2011 | EP2291395A1 Novel and powerful mhc-class ii petptides derived from survivin |
| 03/09/2011 | EP2291394A1 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 03/09/2011 | EP2291393A1 Genes for modulating coffee maturation and methods for their use |
| 03/09/2011 | EP2291392A1 Bifunctional molecules for inhibiting hiv entry |
| 03/09/2011 | EP2291199A2 Capsulating system binding to nucleolin |
| 03/09/2011 | EP2291188A2 Compositions and methods to protect cells by blocking entry of pathogen proteins |